J. David Grimes

560 total citations
22 papers, 398 citations indexed

About

J. David Grimes is a scholar working on Neurology, Surgery and Rheumatology. According to data from OpenAlex, J. David Grimes has authored 22 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 4 papers in Surgery and 4 papers in Rheumatology. Recurrent topics in J. David Grimes's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (7 papers) and Glycogen Storage Diseases and Myoclonus (4 papers). J. David Grimes is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (7 papers) and Glycogen Storage Diseases and Myoclonus (4 papers). J. David Grimes collaborates with scholars based in Canada and United States. J. David Grimes's co-authors include Mohamed N. Hassan, Joseph Jankovic, Linda A. Hershey, Harold L. Klawans, Robert Feldman, Charles H. Markham, Stanley Fahn, Ira Shoulson, Manfred D. Muenter and Roger Kurlan and has published in prestigious journals such as Neurology, SLEEP and Movement Disorders.

In The Last Decade

J. David Grimes

21 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. David Grimes Canada 11 289 97 59 41 38 22 398
A. Vázquez Spain 12 297 1.0× 77 0.8× 52 0.9× 40 1.0× 33 0.9× 21 457
David A. Owen United Kingdom 9 133 0.5× 84 0.9× 22 0.4× 27 0.7× 31 0.8× 11 288
Ejner Pedersen Denmark 12 128 0.4× 98 1.0× 96 1.6× 13 0.3× 32 0.8× 33 401
Ján Benetin Slovakia 10 315 1.1× 48 0.5× 88 1.5× 16 0.4× 49 1.3× 22 479
Stanisław Ochudlo Poland 10 371 1.3× 120 1.2× 127 2.2× 19 0.5× 18 0.5× 34 542
Manuel María Fernández Pardal Argentina 8 211 0.7× 125 1.3× 84 1.4× 16 0.4× 5 0.1× 15 323
Zlatko Trkanjec Croatia 9 114 0.4× 52 0.5× 35 0.6× 26 0.6× 17 0.4× 43 346
Helena Nissinen Finland 6 434 1.5× 99 1.0× 45 0.8× 74 1.8× 6 0.2× 6 500
D. Prayer Austria 10 144 0.5× 83 0.9× 12 0.2× 12 0.3× 40 1.1× 22 358
Phyllis Salzman United States 11 61 0.2× 79 0.8× 115 1.9× 12 0.3× 23 0.6× 16 396

Countries citing papers authored by J. David Grimes

Since Specialization
Citations

This map shows the geographic impact of J. David Grimes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. David Grimes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. David Grimes more than expected).

Fields of papers citing papers by J. David Grimes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. David Grimes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. David Grimes. The network helps show where J. David Grimes may publish in the future.

Co-authorship network of co-authors of J. David Grimes

This figure shows the co-authorship network connecting the top 25 collaborators of J. David Grimes. A scholar is included among the top collaborators of J. David Grimes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. David Grimes. J. David Grimes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grimes, J. David, et al.. (2017). 0602 CENTRAL SLEEP APNEA IN THE ACUTE AND STABLE PHASES OF STROKE. SLEEP. 40(suppl_1). A223–A223. 1 indexed citations
2.
Grimes, David A., et al.. (2002). Large French‐Canadian family with Lewy body parkinsonism: Exclusion of known loci. Movement Disorders. 17(6). 1205–1212. 2 indexed citations
3.
Grimes, J. David, et al.. (1995). Toxic Shock Syndrome as a Complication of Orthopaedic Surgery. Journal of Pediatric Orthopaedics. 15(5). 666–671. 10 indexed citations
4.
Olanow, C. Warren, Stanley Fahn, Manfred D. Muenter, et al.. (1994). A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease. Movement Disorders. 9(1). 40–47. 166 indexed citations
5.
Mendis, Tilak, et al.. (1994). Symptomatic relief from treatment‐induced psychosis in Parkinson's disease: An open‐label pilot study with remoxipride. Movement Disorders. 9(2). 197–200. 11 indexed citations
6.
Kerr, Robert, et al.. (1993). Complex Motor Performance and Parkinson's Disease. Canadian Journal on Aging / La Revue canadienne du vieillissement. 12(1). 89–101. 1 indexed citations
7.
Mohr, Erich, et al.. (1992). SYMPTOMATIC RELIEF FROM TREATMENT INDUCED PSYCHOSIS IN PARKINSONʼS DESEASE: A PILOT STUDY WITH REMOXIPRIDE. Clinical Neuropharmacology. 15. 139B–139B. 1 indexed citations
8.
Grimes, J. David. (1991). Deprenyl: The Exciting Possibility of Protective Effect. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 18(1). 85–86. 1 indexed citations
9.
Thakar, Jay H., Mohamed N. Hassan, & J. David Grimes. (1988). 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 12(2-3). 355–362. 3 indexed citations
10.
Grimes, J. David, Mohamed N. Hassan, & Jay H. Thakar. (1987). Antioxidant Therapy in Parkinson's Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 14(S3). 483–487. 19 indexed citations
11.
Grimes, J. David, et al.. (1985). Bromocriptine. Clinical Neuropharmacology. 8(1). 73–77. 16 indexed citations
12.
Grimes, J. David, et al.. (1985). Radial Compression Neuropathy in Advanced Parkinson's Disease. Archives of Neurology. 42(7). 695–696. 12 indexed citations
13.
Grimes, J. David. (1984). Bromocriptine in Parkinson’s Disease: Results Obtained With High and Low Dose Therapy. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 11(S1). 225–228. 6 indexed citations
14.
Grimes, J. David, et al.. (1984). Bromocriptine in the Management of End of Dose Deterioration in Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 11(4). 452–456. 5 indexed citations
15.
Grimes, J. David & Mohamed N. Hassan. (1983). Bromocriptine in the Long-Term Management of Advanced Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 10(2). 86–90. 10 indexed citations
16.
Grimes, J. David, et al.. (1982). Delayed‐onset posthemiplegic dystonia. Neurology. 32(9). 1033–1033. 40 indexed citations
17.
Molina-Negro, P., et al.. (1982). Bromocriptine (parlodelR) in the treatment of parkinson's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 6(4-6). 503–508. 4 indexed citations
18.
Grimes, J. David. (1982). Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.. PubMed. 126(5). 468–468. 3 indexed citations
19.
Grimes, J. David & Mohamed N. Hassan. (1981). Method of Addition of Bromocriptine to the Drug Regime of Patients with Advanced Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 8(1). 31–34. 6 indexed citations
20.
Grimes, J. David, et al.. (1972). Idiopathic hypoparathyroidism with impaired vitamin B 12 absorption and neuropathy.. PubMed. 107(1). 54–6 passim. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Vázquez Breakdown of academic impact, for papers by David A. Owen Breakdown of academic impact, for papers by Ejner Pedersen Breakdown of academic impact, for papers by Ján Benetin Breakdown of academic impact, for papers by Stanisław Ochudlo Breakdown of academic impact, for papers by Manuel María Fernández Pardal Breakdown of academic impact, for papers by Zlatko Trkanjec Breakdown of academic impact, for papers by Helena Nissinen Breakdown of academic impact, for papers by D. Prayer Breakdown of academic impact, for papers by Phyllis Salzman
Rankless by CCL
2026